IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NLS Pharmaceutics LTD

CUSIP: H57830103 | 24 institutional holders

Quarters

Q3 2025Q2 2025Q2 2024Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2025

CoreCap Advisors, LLC36
0.0% of portfolio›$66
StyleTurnoverLocationFiled
CoreCap Advisors, LLC
36$660.0%ETFMediumSouthfield, MI2025-10-22